Rhythm Pharmaceuticals Inc (RYTM): A Case For Going Higher

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.

Stocks Info

This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Rhythm Pharmaceuticals Inc is $3.65B. A total of 2.12 million shares were traded on the day, compared to an average of 576.33K shares.

In the most recent transaction, PAMELA CRAMER bought 20,760 shares of RYTM for 54.96 per share on Apr 08 ’25. In a previous transaction on Apr 08 ’25, YANN MAZZABRAUD bought 17,750 shares at 54.96 per share.

Among the insiders who sold shares, German Christopher Paul disposed of 344 shares on Mar 21 ’25 at a per-share price of $54.23. This resulted in the Corporate Controller & CAO holding 2,889 shares of RYTM after the transaction. In another insider transaction, Mazabraud Yann sold 75,000 shares at $51.48 per share on Mar 14 ’25. Company shares held by the EVP, Head of International now total 40,370.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, RYTM has a high of $68.58 and a low of $35.17.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. RYTM’s latest balance sheet shows that the firm has $294.86M in Cash & Short Term Investments as of fiscal 2021. There were $2.55M in debt and $43.43M in liabilities at the time. Its Book Value Per Share was $0.35, while its Total Shareholder’s Equity was $284.15M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RYTM is Buy with a score of 4.92.

Most Popular

Related Posts